If You Missed Tesla, Here's Your "Second Chance"...
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Shares Stats
| Shares Outstanding | 28,020,000 |
| Shares Float | 22,640,000 |
| Shares Short | 3,060,000 |
| Insider Holdings | 2084% |
| Institution Holdings | 93.51% |
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
General
| Name | Medpace Holdings Inc |
| Ticker | MEDP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 6,000 |
Highlights
| Analyst Target | 418.40 |
| Market Cap | 11,885,900,000 |
| PE Ratio | 31.46 |
| PEG Ratio | 3.53 |
| EBITDA | 506,476,992 |
Financials
| Curr Year EPS Estimate | 14.37 |
| Next Quarter EPS Estimate | 3.05 |
| Profit Margin | 18.74% |
| Operating Margin | 21.40 |
| Return on Assets | 0.17 |
| Return on Equity | 0.89 |
| Revenue | 2.2B |
| Earnings Per Share | 13.45 |
| Revenue Per Share | 73.80 |
| Gross Profit | 1,529,083,008 |
| Quarterly Revenue Growth | 0.14 |
Valuation
| Trailing PE | 31.46 |
| Forward PE | 30.96 |
| Price/Sales (Trailing 12 Mt.) | 5.33 |
| Price/Book (Most Recent Quarter) | 68.96 |
Earnings
Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD
Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.
What's Going On With Tesla Stock Today?
Tesla stock, after initially trading lower on Friday, has recovered to trade flat midday. The early session dip was in line with broader market weakness following a surprisingly soft U.S. jobs report.
Hidden $5 AI Manufacturer Revealed - Ad
The company manufacturing Nvidia's AI servers trades under a secret name. AI revenue: $30B this year. Stock price: $5.
Ukrainian Parliament approves law ensuring independence of anti-graft watchdogs
KYIV, Ukraine (AP) — Ukraine’s Parliament on Thursday overwhelmingly approved a bill presented by President Volodymyr Zelenskyy that of two of the country’s key anti-corruption watchdogs, reversing his last week that curbed their power and brought an outcry.
Debt and delayed care forecast for some who lose insurance under tax and spending law
Delayed treatments, canceled doctor visits, skipped prescriptions. Losing insurance is bad for your health.
If You Own Tesla Stock, This Might Change Everything - Ad
Jeff Brown, an early Tesla bull, warns of a strange "Tesla Glitch" uncovered by Wall Street legend Larry Benedict. This anomaly has preceded $25B-$100B swings in Tesla's value - and he's using it to anticipate moves without buying or shorting a single share.
Why AGCO Stock Is Surging After Q2 Results
AGCO reports strong Q2 results, exceeding expectations in a challenging agricultural market. Shares rose as 2025 guidance was raised.
These 3 Dividend-Yielding Stocks Could Outperform As High Fed Rates Spark $4.9 Billion Inflows: Expert
Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Dan Bongino Stunned by FBI's Recent Corruption Findings: 'I'll Never Be the Same After Learning What I've Learned'
FBI Deputy Director Dan Bongino has expressed deep concern over the discoveries of government corruption and weaponization.
New Jersey US Attorney Fired After Being Chosen Over Former Trump Lawyer Alina Habba
The U.S. Attorney for the District of New Jersey, Desiree Leigh Grace, has been dismissed by the Justice Department.
$5 Stock Building Nvidia's AI Servers - Ad
Nuclear stocks gained 51% as energy vampires drain grids . $2B+ revenue, Big Tech pays rent . Massive power opportunity brewing.
Mark Cuban Says This Trump Administration Move Is 'One Of the Dumbest….'
Mark Cuban slams Commerce Dept's plan to charge patent holders a percentage of their patent value as 'dumbest idea in business history'.
Denny's CEO Asks Potential Hires Only Two Questions But Reveals It 'Doesn't Matter What The Questions Are' — Here's Why
Denny's CEO Kelli Valade shares her hiring strategy of looking for red flags and self-awareness through thoughtful questions, not just answers.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Europe's central bank to hold off on another rate cut until it knows how bad the tariff blow will be
FRANKFURT, Germany (AP) — The European Central Bank will likely hold off on making another interest rate cut Thursday, choosing to wait until it can measure the size of any economic blow from .
Cathie Wood Doubles Down On Tesla Despite Leadership Exodus, Dumps $22 Million Of Crypto Stocks Amid Bitcoin Buzz
Cathie Wood-led Ark Invest made significant trades on Tuesday, involving major companies like Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Could Trump Accounts Turn American Babies Into Tomorrow's Millionaires? Here's What Experts Say
A new federal savings initiative, known as "Trump accounts," signed into law by President Donald Trump, could significantly alter the financial future of millions of American children.
Temu accused by EU regulators of failing to prevent sale of illegal products
LONDON (AP) — Chinese online retailer Temu was accused by European Union watchdogs on Monday of failing to prevent the sale of illegal products on its platform.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Samsung Electronics Shares Fall 2.54% Following Tesla's $16.5 Billion AI Chip Manufacturing Agreement
Samsung Electronics Co. Ltd. shares declined 2.54% following Tesla Inc.'s confirmation of a $16.5 billion chip manufacturing partnership.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
'Superman' Flies Past $400 Million But Falters Overseas, While 'Jurassic World Rebirth' Charges Toward $650 Million In A Red-Hot Summer Box Office Battle
Warner Bros.' Superman crossed $400 million globally despite weak overseas performance, while Universal's Jurassic World Rebirth nears $650 million in a competitive summer box office season led by major franchise films.
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs
On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Stakin
Leaked Memo Reveals AI's Next Land Grab - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
What's Going On With Builders FirstSource Stock Today?
Builders FirstSource beat Q2 EPS but missed on sales, cut its FY25 outlook, and saw margins shrink, sending shares down over 3%.
Can Apple's Slim iPhone And Cheaper Macs Reverse The 2025 Stock Slump?
Apple is expected to rebound in the second half of 2025 with new product launches and strong momentum in its Services division. Analysts reaffirmed a Buy rating with a price forecast of $235.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78.
Beef: It's What's for Dinner — If You Can Afford It
Here's a look at why beef is the latest item driving grocery bills higher.
Hidden $5 AI Manufacturer Revealed - Ad
The company manufacturing Nvidia's AI servers trades under a secret name. AI revenue: $30B this year. Stock price: $5.
Meta's Strong Revenues May Offset Concerns Over Soaring AI Investments: Analyst
Meta Platforms poised for market focus on expanding AI initiatives, with aggressive recruitment of top-tier AI professionals and elevated estimates for revenue and EPS.
The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008
A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.
If You Own Tesla Stock, This Might Change Everything - Ad
Jeff Brown, an early Tesla bull, warns of a strange "Tesla Glitch" uncovered by Wall Street legend Larry Benedict. This anomaly has preceded $25B-$100B swings in Tesla's value - and he's using it to anticipate moves without buying or shorting a single share.
Jack Dorsey's Block, With Over $1 Billion In Bitcoin Holdings, Set To Join S&P 500 — Shares Pop 8% In Overnight Trading
Block, Inc. (NYSE:XYZ) shares are soaring in overnight trading on Sunday ahead of the S&P 500 debut of the Jack Dorsey-founded fintech company.
Jim Cramer: This Consumer Defensive Stock Is 'Pretty Expensive'
On CNBC's “Mad Money Lightning Round,” Jim Cramer said that although CoreWeave, Inc. (NASDAQ:CRWV) is good, but Nvidia (NASDAQ:
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Barbara Corcoran, Who Sold Her Real Estate Empire For $66 Million Decades Ago, Says This Is The 'Most Under-Utilized' Tool In The Workplace
Real estate millionaire Barbara Corcoran built a $20 billion brokerage by making work fun with picnics, rewards, and perks, not strict rules.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.